SALMA HAJ-IBRAHIM: Open Payments
NPI 1821621202 · SOMERVILLE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$260 in 14 payments from 10 companies in 2025. Trend: 2023 $115 · 2024 $241 · 2025 $260
Food & beverage: $260
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $72 |
| Ipsen Biopharmaceuticals, Inc | 2 | $37 |
| Aveo Pharmaceuticals, Inc. | 1 | $24 |
| TAIHO ONCOLOGY, INC. | 1 | $23 |
| Genmab U.S., Inc. | 1 | $22 |
| Janssen Biotech, Inc. | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
| Deciphera Pharmaceuticals Inc. | 1 | $16 |
| Amneal Pharmaceuticals LLC | 1 | $15 |
| Merck Sharp & Dohme LLC | 1 | $14 |
Products named: Onivyde, RINVOQ, FOTIVDA, LONSURF, Epkinly, SKYRIZI, DARZALEX, PLUVICTO.
Industry payments across NJ — which companies pay providers there.
